Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Liming Xia
Observed name:
Li-ming Xia
Institution:
Anhui University of Traditional Chinese Medicine
Observed institutions:
Anhui University of Traditional Chinese Medicine,
Shanghai University of Traditional Chinese Medicine
ORCID:
0000-0001-8510-632X
Observed ORCID:
0000-0001-8510-632X
OpenAlex ID:
A5101819519
Severe delayed pulmonary toxicity following PD‐L1–specific CAR‐T cell therapy for non‐small cell lung cancer
2020
·
Heping Liu
, Yuxiang Ma
, et al.
·
Clinical & Translational Immunology
·
36
PDF
Taurochenodeoxycholic acid inhibits the proliferation and invasion of gastric cancer and induces its apoptosis
2021
·
Dongwei Zhang
, Yongfu Zhu
, et al.
·
Journal of Food Biochemistry
·
15
PDF
The efficacy and safety of the combination of axitinib and pembrolizumab‐activated autologous DC‐CIK cell immunotherapy for patients with advanced renal cell carcinoma: a phase 2 study
2021
·
Meng‐Jia Song
, Qiu‐Zhong Pan
, et al.
·
Clinical & Translational Immunology
·
10
PDF
Long‐term survival analysis of patients with stage IIIB‐IV non‐small cell lung cancer complicated by type 2 diabetes mellitus: A retrospective propensity score matching analysis
2022
·
Xuejiao Li
, Haiyan Fang
, et al.
·
Thoracic Cancer
·
7
Mechanistic insights into traditional Chinese medicine for digestive tract cancers: implications for gastric, hepatic, esophageal, intestinal, and pancreatic tumors
2024
·
Yong-fu Zhu
, Chang Liu
, et al.
·
ONCOLOGIE
·
4
PDF
The global, regional, and national burden of secondhand smoke-related tracheal, bronchus, and lung cancer: Results from the Global Burden of Disease study 2021
2025
·
Jinfeng Yao
, Liming Xia
, et al.
·
Tobacco Induced Diseases
·
3
PDF
Compound shougong powder inhibits the malignant phenotype of hepatocellular carcinoma cells by targeting the DNA damage repair pathway
2023
·
Yong-fu Zhu
, Jing Xu
, et al.
·
Journal of Pharmacy and Pharmacology
·
3
Efficacy and safety of camrelizumab-based regimens in advanced squamous cell carcinoma patients: a prospective multicenter study
2026
·
Weijia Jiang
, Wanren Peng
, et al.
·
Frontiers in Pharmacology
PDF
Show more works
View as search
Works count:
8
Citation count:
78
H-index:
4
I10-index:
3
Year
Topic
Type